Breast Cancer Breakthroughs Episode 11 – Changing the Game with New Hormone Therapies for ER-Positive Breast Cancer
For the past 20 years, people with early estrogen receptor-positive (ER+) breast cancer have received a standard treatment, including hormone therapies like aromatase inhibitors or tamoxifen. While these patients generally have good outcomes after this treatment, they are still at risk for recurrence. As researchers seek more targeted and effective treatments for people with early […]